Antiangiogenic and antitumor agents: Design, synthesis, and evaluation of novel 2-amino-4-(3-bromoanilino)-6-benzylsubstituted pyrrolo[2,3-d]pyrimidines as inhibitors of receptor tyrosine kinases
- 17 November 2003
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 11 (23), 5155-5170
- https://doi.org/10.1016/j.bmc.2003.08.034
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Diagnostic and Prognostic Significance of Tumor AngiogenesisPublished by Springer Science and Business Media LLC ,2002
- Receptor Tyrosine Kinases in AngiogenesisPublished by Springer Science and Business Media LLC ,2002
- Tyrosine kinase inhibitors: From rational design to clinical trialsMedicinal Research Reviews, 2001
- Inhibition of tumor angiogenesis by synthetic receptor tyrosine kinase inhibitorsDrug Discovery Today, 2000
- New paradigms for the treatment of cancer: The role of anti-angiogenesis agentsAdvances in Cancer Research, 2000
- Strategies toward the Design of Novel and Selective Protein Tyrosine Kinase InhibitorsPharmacology & Therapeutics, 1999
- Molecular mechanisms of tumor metastasis and angiogenesis.Langenbecks Archiv für Chirurgie, 1999
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- The influence of angiogenesis research on management of patients with breast cancerBreast Cancer Research and Treatment, 1995
- Transplacental Carcinogenesis by StilbestrolThe New England Journal of Medicine, 1971